Oxford Silk Phage Technology, in collaboration with the University of Exeter and the University of Hertfordshire, has been awarded 2 million British pounds via a new Collaborative Innovate UK Biomedical Catalyst grant. The funds will accelerate pre-clinical development of OSPT’s first product, aimed at reducing patients’ risk of surgical site infections.